NIH Radio
NIH study finds two doses of HPV vaccine may be as protective as full course – 2
Narrator: This is NIH Health Matters. I’m Joe Balintfy. An NIH-funded vaccine trial has found that two doses of a vaccine against the human papillomavirus may be enough to help protect against the cervical cancer-causing virus. Dr. Aimée Kreimer at the NIH explains the study contains more than seven-thousand women.
Kreimer: We intended for women to get the standard regimen which was three doses. But for some women about 20 percent of our population received actually less than three doses and this was typically for involuntary reasons, such as pregnancy.
Narrator: She adds that if other studies confirm these findings, researchers may be one step closer to preventing cervical cancer. For details, visit www.cancer.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
Contact Us
Send questions or comments to:
Joe Balintfy
NIH News Media Branch
NIHRadio@mail.nih.gov
301-435-7557
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.
Social Media Links